Netherlands
Medizinprodukt-Marktintelligenz für Netherlands. Regulatorische Änderungen, Wettbewerber und Beschaffungstrends.
Länder-Tabelle zuletzt: 7. Aug. 2026 (kann veraltet sein). 7-Tage-Zahl ist live neu berechnet. Tabellenwert war 45.
Signale der letzten 7 Tage
Medicines and Medical Devices Shortages Specialist - careers.ema.europa.eu
ICH E6 (R3) Guideline on good clinical practice (GCP)_Step 5 - European Medicines Agency (EMA)
ICH M4Q (R2) Guideline on the common technical document for the registration of pharmaceuticals for human use: quality_Step 2b - ema.europa.eu
Guideline on quality, non-clinical and clinical aspects of medicinal products containing genetically modified cells - European Medicines Agency (EMA)
2.4 Challenges and opportunities in medicines and medical devices development - introduction to breakout sessions - S. Dias (EMA - European Medicines Agency (EMA)
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 September 2026
Draft guideline on the investigation of interactions in the gastrointestinal tract
ICH guideline E8(R1) Step 2b on general considerations for clinical studies - European Medicines Agency (EMA)
Assessment templates and guidance - Ancillary medicinal substances incorporated in a medical device - European Medicines Agency (EMA)
Product-information (QRD) templates - Human - European Medicines Agency (EMA)
Draft guideline on clinical investigation of medicinal products for the treatment of migraine and cluster headache - Revision 2
CHMP opinions on consultation procedures on ancillary substances incorporated in a medical device - European Medicines Agency (EMA)